Private equity firm Francisco Partners has completed its acquisition of healthcare IT systems provider QuadraMed Corporation.
Following the acquisition, QuadraMed’s common stock will no longer be listed for trading on the NASDAQ Global Market.
Common stockholders of QuadraMed will receive USD8.50 in cash for each share owned, while Series A preferred stockholders are entitled to receive USD13.7097 in cash for each share of Series A preferred stock owned, other than dissenting shares.
QuadraMed’s president and CEO, Duncan W James, said that Francisco Partners has "extensive resources and a proven track record of helping healthcare IT companies execute on their strategic and operational goals".